Infantile Spasms: What to Do When ACTH Has Not Achieved Cessation of Spasms and Resolution of Hypsarrhythmia
When initial hormonal therapy for infantile spasms does not produce the expected clinical response within the anticipated window, a clearly defined next-line protocol is indicated. This page outlines the escalation scenario and the treatment direction involved.
Previous Line — Failure Condition
Adrenocorticotropic hormone (ACTH) was used as the first-line short-term treatment for infantile spasms. The expected outcome — complete cessation of spasms and resolution of hypsarrhythmia, with response usually within 2 weeks — was not achieved. This non-response is the condition that triggers escalation to the next protocol step.
Next-Line Approach (Overview Only)
The next-line protocol employs a specific antiseizure agent for short-term treatment of infantile spasms. The clinical goal is cessation of spasms and resolution of hypsarrhythmia within 14 days of initiating therapy. The full protocol — including selection criteria, dosing guidance, and monitoring considerations — is available via the link below.
References
- Vigabatrin is possibly effective for the short-term treatment of infantile spasms (level C, class III and IV evidence).
- Vigabatrin appears to be effective within 14 days of initiation of therapy.
View source ↗